MedPath

Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Smoking
Interventions
Other: Pharmacist-delivered group program for smoking cessation
Other: Brief standard care session for smoking cessation delivered over the telephone
Registration Number
NCT00670904
Lead Sponsor
University of Montana
Brief Summary

This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Smoked one or more cigarettes daily for 7 days
  • Somewhat ready to quit in the next 2 weeks (4 or more on a 10- point scale)
  • Willing and capable of attending three scheduled sessions at the clinic
  • Interested in participating in the study
Exclusion Criteria
  • Planned to leave the area in the next 6 months
  • Used pharmacotherapy for smoking cessation in the last 30 days
  • Used other forms of tobacco in the last 30 days
  • Schizophrenia
  • Prior participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Pharmacist-delivered group program for smoking cessationPharmacist-delivered group program for smoking cession.
2Brief standard care session for smoking cessation delivered over the telephoneBrief standard care session for tobacco smoking cessation delivered over the telephone.
Primary Outcome Measures
NameTimeMethod
The primary outcome variable for the study was biochemically verified 7-day point prevalence smoking cessation at 6 months, defined as having smoked no cigarettes - not even a puff - for the previous 7 days.6 months
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes included 30-day point prevalence abstinence and prolonged abstinence (>6 months).6 months

Trial Locations

Locations (1)

Missoula VA Clinic

🇺🇸

Missoula, Montana, United States

© Copyright 2025. All Rights Reserved by MedPath